NB
ABOS icon

NBT Bank’s Acumen Pharmaceuticals ABOS Stock Holding History

NBT Bank’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472 Buy
200
+198
+9,900% +$505 ﹤0.01% 1006
2025
Q4 		$422 Hold
2
– – ﹤0.01% 799
2025
Q3 		$342 Sell
2
-198
-99% -$274 ﹤0.01% 795
2025
Q2 		$232 Buy
+200
New +$215 ﹤0.01% 780

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

NBT Bank's ABOS Position: Q1 2026 in Review

NBT Bank increased its Acumen Pharmaceuticals (ABOS) stake by 9,900% in Q1 2026, buying an estimated $505 and bringing the position to 200 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

NBT Bank first reported a position in ABOS in Q2 2025 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • NBT Bank held 200 shares of Acumen Pharmaceuticals worth $472 as of Q1 2026.
  • NBT Bank bought 198 Acumen Pharmaceuticals shares in Q1 2026, an estimated $505.
  • Acumen Pharmaceuticals made up ﹤0.01% of NBT Bank's portfolio in Q1 2026, its #1006 holding.
  • NBT Bank first reported a position in Acumen Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.